The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2017 | Immunotherapy and its dependence on T-cells
Marion Subklewe
• 22 Jun 2017
Marion Subklewe, MD, from LMU-University Hospital, Munich, Germany, discusses the necessity to monitor T-cell count in patients who will be subject to immunotherapy and to make sure that patients do not receive any prior treatment that would affect their T-cell count (e.g. cytarabine). This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.
